Debates between Sarah Champion and Theo Clarke during the 2019-2024 Parliament

Sexual and Reproductive Health and Rights: Overseas Aid

Debate between Sarah Champion and Theo Clarke
Wednesday 12th July 2023

(1 year, 5 months ago)

Westminster Hall
Read Full debate Read Hansard Text Read Debate Ministerial Extracts

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Theo Clarke Portrait Theo Clarke (Stafford) (Con)
- Hansard - - - Excerpts

I thank the hon. Lady for securing this debate. Does she agree that the Government are right to commit to focusing spending on women and girls, and particularly on maternal mental health? Will she call for the UK to publish a voluntary national review on the sustainable development goals, given the importance of this subject?

Sarah Champion Portrait Sarah Champion
- Hansard - -

I absolutely support what the hon. Lady says. She is a member of the International Development Committee, and the Chair of the International Development Sub-Committee on the work of the Independent Commission for Aid Impact. She has always been a champion on these issues, and the Minister has heard what she said.

The FCDO’s programming does not address the global burden of gynaecological disease as a priority in its own right, or as a key element of its integrated SRHR response. That is a glaring omission. Forthcoming RCOG research shows that overall morbidity for women and girls due to so-called benign gynaecological conditions outweighs—I was stunned when I heard this—the combined morbidity from malaria, tuberculosis and HIV/AIDS in low and middle-income countries; yet gynaecological conditions are not in the FCDO’s strategy. There is an urgent need for the UK Government and donors around the world to afford gynaecological disease the same priority as maternal mortality and diseases such as malaria, TB and HIV/AIDS. Can the Minister look into that?

As a first step, RCOG and I are seeking a commitment from the UK Government to championing the issue by investing in the collection of data and research on the scale of the burden, so that we build strong evidence on which to base future investment. Investing in quality SRHR training for all healthcare workers should be a top priority. At present, the workforce meets only 41% of the needs of low-income countries. A lack of skilled workers is a major barrier to making universal health coverage a reality. I welcome the Government’s commitment to strengthening the workforce as part of their contribution to that agenda, but as RCOG recommends, we need greater investment to support task-shifting and task-sharing between different groups and levels of healthcare workers. That is essential if we are to address shortages; support the delivery of comprehensive, integrated SRHR services, including expanded access to abortion care and long-acting reversible contraception; and support the diagnosis and treatment of gynaecological disease at the earliest stage.

The new report from RCOG is an important reminder to us all—and to the Minister—of our responsibility to women and girls around the world, who rely on our Government’s support for their essential healthcare. It should also serve as a call to action, so that we resume the progress that is needed to achieve universal access to SRHR. I urge the Minister to seriously consider the report’s recommendations for investment, as well as the points that I have raised today. We must stand together, alongside women and girls everywhere, and continue to advocate for their health, empowerment, and equality.